Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03805217 · ClinicalTrials.gov registry record
Hypotension Prediction Index Study (HPI Study)
A clinical trial, sponsored by Edwards Lifesciences.
- Completed
- Registry status
- 485
- Enrollment target
NCT03805217 is a clinical trial that has completed, run by Edwards Lifesciences. The registered enrollment target is 485 participants.
The verdict
NCT03805217 has completed, sponsored by Edwards Lifesciences.
- COMPLETED
- Registry status
- 485 participants
- Enrollment target
Study Summary
A prospective, single-arm, open-label, multicenter post-approval study to determine whether the use of the Acumen HPI Software to guide intraoperative hemodynamic management in non-cardiac surgery reduces the duration of intraoperative hypotension below a threshold of Mean Arterial Pressure (MAP)
Interventions
- DEVICE EV1000A Clinical Platform with Acumen Hypotension Prediction Index Feature Software
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 485 participants |
| Start Date | 2019-05-16 |
| Est. Completion | 2020-03-17 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03805217
The ClinicalTrials.gov registry entry for NCT03805217 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 485 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Edwards Lifesciences, which has 57 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which EV1000A Clinical Platform with Acumen Hypotension Prediction Index Feature Software is the first listed.
NCT03805217 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03805217 about?
NCT03805217 is a clinical study titled "Hypotension Prediction Index Study (HPI Study)". A prospective, single-arm, open-label, multicenter post-approval study to determine whether the use of the Acumen HPI Software to guide intraoperative hemodynamic management in non-cardiac surgery reduces the duration of intraoperative hypotension below a threshold of Mean Arterial Pressure (MAP)
What is the current status of trial NCT03805217?
This trial is currently completed. The enrollment target is 485 participants. The study started on 2019-05-16. Estimated completion is 2020-03-17.
What interventions are being tested in trial NCT03805217?
The interventions under investigation include: EV1000A Clinical Platform with Acumen Hypotension Prediction Index Feature Software (DEVICE).
Who is sponsoring clinical trial NCT03805217?
This trial is sponsored by Edwards Lifesciences, which has 57 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.